Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 4/3/2026NMPA Suspends Import, Sale and Use of Cadila's Amlodipine Besylate API...
  • 4/3/2026CDE Revises Drug R&D and Technical Review Communication Management Mea...
  • 4/2/2026NMPA Releases Implementation Opinions on "AI + Drug Regulation"
  • 4/2/2026NMPA Issues Notice on Advancing Segmented Manufacturing of Biologics
  • 4/1/2026China CDE Opens Public Consultation on 105th Batch of Chemical Generic...
  • 3/31/2026NMPA Moves to Strengthen China's Conditional Drug Approval Framework
  • 3/30/2026NMPA Releases 103rd Batch of Generic Drug Reference Formulations Catal...
  • 3/26/2026China Issues New Guidelines to Standardize Pharmaceutical Logistics Na...
  • 3/25/2026China Seeks Public Input on Accelerating National Drug Traceability Sy...
  • 3/25/2026China Suspends Imports of Select Indian APIs Over GMP Violations
  • 3/17/2026CDE Issues Guideline on Dose Extrapolation for Neonates and Young Infa...
  • 3/17/2026CDE Seeks Comment on Draft Guideline for Advancing Oncology Drugs to F...
  • 3/11/2026China Releases Trial Guideline for Influenza Vaccine Clinical Studies
  • 3/11/2026China Issues Revised Technical Guideline for HPV Vaccine Clinical Tria...
  • 3/11/2026China Seeks Comments on Draft Technical Guideline for Rare Disease ERT...
  • 3/9/2026China Publishes 102nd Batch of Reference Formulations for Generics and...
  • 3/9/2026NMPA Seeks Input on Draft Guidelines for Quality Summaries of Therapeu...
  • 3/5/2026CDE Issues Guidance on Subject Selection for Oncology Drug Bioequivale...
  • 3/4/2026CDE Invites Feedback on Draft Technical Guideline for Preventive mRNA ...
  • 3/4/2026CDE Issues Technical Guideline on Clinical Trials for Drugs Treating C...
  • 3/2/2026CDE Issues Interim Guidelines for Synthetic Oligonucleotide Innovativ...
  • 2/25/2026CDE Solicits Comments on Batch 104 of Chemical Generic Reference Formu...
  • 2/24/2026China Prepares to Implement Landmark Regulations for Clinical Research...
  • 2/24/2026CDE Issues Guidelines on Benefit-Risk Assessment Using Multi-Regional ...
  • 2/24/2026CDE Releases Q&A Document on Development Safety Update Reports
  • 2/24/2026CDE Issues Guideline on Clinical Information for CAR-T Therapy Package...
  • 2/12/2026CDE Issues Draft Pharmaceutical Guidance for Rare Disease Chemical Dru...
  • 2/9/2026CDE Issues Technical Guideline for Generic Sodium Iodide [131I] Oral S...
  • 2/5/20262026 National Conference on Drug Registration and Post-Market Regulati...
  • 2/5/2026CDE Issues Trial Guideline for Neuropathic Pain Drug Development
  • Page:1/8 Total number of articles:231: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group